Suppr超能文献

生物素酶缺乏症:新方向与实际关注点

Biotinidase Deficiency: New Directions and Practical Concerns.

作者信息

Wolf Barry

机构信息

Department of Pediatrics, Division of Research, Connecticut Children's Medical Center, 282 Washington Street, Hartford, CT 06106, USA.

出版信息

Curr Treat Options Neurol. 2003 Jul;5(4):321-328. doi: 10.1007/s11940-003-0038-4.

Abstract

Biotinidase deficiency is a readily treatable inherited disorder. Discovery of the enzyme deficiency as the cause for late-onset multiple carboxylase deficiency initially seemed to answer almost all of the questions about the disorder. However, as is the case for most inborn errors of metabolism, finding the enzyme that causes the disorder, cloning the gene, and determining the spectrum of clinical features of the disease only opens a Pandora's box. As researchers have found, there are still many important and interesting questions about this disorder that must be addressed and answered. However, when compared with other inherited metabolic diseases, biotinidase deficiency is still one of the most readily treatable. If a child must have an inborn error of metabolism, let it be biotinidase deficiency and let it be identified by newborn screening.

摘要

生物素酶缺乏症是一种易于治疗的遗传性疾病。最初发现这种酶缺乏是迟发性多种羧化酶缺乏症的病因,这似乎几乎回答了关于该疾病的所有问题。然而,如同大多数先天性代谢缺陷一样,找到导致该疾病的酶、克隆基因以及确定疾病的临床特征谱,仅仅是打开了一个潘多拉魔盒。正如研究人员所发现的,关于这种疾病仍有许多重要且有趣的问题必须得到解决和回答。然而,与其他遗传性代谢疾病相比,生物素酶缺乏症仍然是最易于治疗的疾病之一。如果一个孩子必须患有先天性代谢缺陷,但愿是生物素酶缺乏症,并且能通过新生儿筛查被发现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验